Real-World Study of EGFR-TKIs Combined With Radiotherapy in Patients With Brain Metastases From Non-small Cell Lung Cancer

被引：0
|
作者：
Liu, Yi [1 ]
Zhu, Yaning [1 ]
机构：
[1] Shaanxi Prov peoples Hosp, Dept Oncol, Xian, Peoples R China
来源：
JOURNAL OF THORACIC ONCOLOGY | 2023年 / 18卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
PP.06
引用
收藏
页码：S11 / S11
页数：1
相关论文
共 50 条
  • [21] Safety of EGFR-TKIs for EGFR mutation-positive non-small cell lung cancer
    Zhou, Jia-Ying
    Liu, Si-Yang
    Wu, Yi-Long
    EXPERT OPINION ON DRUG SAFETY, 2020, 19 (05) : 589 - 599
  • [22] A retrospective real-world study: the efficacy of immune-related combination therapies in advanced non-small cell lung cancer after resistance to EGFR-TKIs
    Cai, Ruoxue
    Liu, Ying
    Yu, Mingyan
    Sha, Huanhuan
    Guo, Mengya
    Chen, Yue
    Ye, Jinjun
    Zhou, Guoren
    Fang, Ying
    Shen, Bo
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2023, 72 (12) : 4355 - 4365
  • [23] A retrospective real-world study: the efficacy of immune-related combination therapies in advanced non-small cell lung cancer after resistance to EGFR-TKIs
    Ruoxue Cai
    Ying Liu
    Mingyan Yu
    Huanhuan Sha
    Mengya Guo
    Yue Chen
    Jinjun Ye
    Guoren Zhou
    Ying Fang
    Bo Shen
    Cancer Immunology, Immunotherapy, 2023, 72 : 4355 - 4365
  • [24] Furmonertinib treatment in patients with EGFR-mutated non-small cell lung cancer and leptomeningeal metastases: A real-world study
    Chen, H.
    Wang, L.
    Wu, Y.
    Wu, Y.
    Ma, S.
    Sen, Y.
    Zhen, H.
    Mo, Y.
    Zhang, C.
    Wang, Q.
    ANNALS OF ONCOLOGY, 2023, 34 : S1697 - S1697
  • [25] Radiotherapy in brain metastases from EGFR-mutated non-small cell lung cancer
    Bhandari, Shruti
    Dunlap, Neal
    Kloecker, Goetz
    JOURNAL OF THORACIC DISEASE, 2021, 13 (05) : 3230 - 3234
  • [26] The effectiveness of EGFR-TKIs against brain metastases in EGFR mutation-positive non-small-cell lung cancer
    Bai, Hao
    Xiong, Liwen
    Han, Baohui
    ONCOTARGETS AND THERAPY, 2017, 10 : 2335 - 2340
  • [27] The efficacy of immune checkpoint inhibitors in advanced EGFR-Mutated non-small cell lung cancer after resistance to EGFR-TKIs: Real-World evidence from a multicenter retrospective study
    Hu, Jia
    Huang, Di
    Wang, Yanrong
    Li, Donghui
    Yang, Xuejiao
    Fu, Yan
    Du, Nan
    Zhao, Yan
    Li, Xiaosong
    Ma, Junxun
    Hu, Yi
    FRONTIERS IN IMMUNOLOGY, 2022, 13
  • [28] Multibiomarker analysis homing in on EGFR-TKIs therapy in non-small cell lung cancer
    Bai, H.
    An, T.
    Zhuo, M.
    Zhao, J.
    Wu, M.
    Duan, J.
    Yang, L.
    Wang, Z.
    Wang, J.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [29] Factors on survival for patients of EGFR mutation advanced lung adenocarcinoma with EGFR-TKIs combined with radiotherapy: Real-world data from single center.
    Wang, Yuxiang
    Yu, Wenjian
    Shi, Jian
    Jiang, Nan
    Wang, Zhoufan
    Yang, Jie
    Jia, Zhongfei
    Song, Meng
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [30] A retrospective study of radiotherapy combined with immunotherapy for patients with baseline brain metastases from non-small cell lung cancer
    Lu, Ruoyu
    Wang, Ziqi
    Tian, Wentao
    Shi, Wen
    Chu, Xianjing
    Zhou, Rongrong
    SCIENTIFIC REPORTS, 2025, 15 (01):
12345